BRTX Stock Analysis: Buy, Sell, or Hold?
BRTX - BioRestorative Therapies, Inc. Common Stock (NV)
$1.15
0.01 (0.88%)
▲
5d:
+2.68%
30d:
-2.13%
90d:
-23.84%
BUY
HIGH Confidence
Last Updated: February 2, 2026
Earnings: Mar 26, 2026
Get Alerted When BRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BRTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: BRTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: BRTX is currently trading at $1.15, which is considered fair relative to its 30-day fair value range of $1.12 to $1.19.
Technical Outlook: Technically, BRTX is in a strong downtrend. Immediate support is located at $1.06, while resistance sits at $1.19.
Market Sentiment: BRTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+1030.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BRTX is in a strong downtrend. Immediate support is located at $1.06, while resistance sits at $1.19.
Market Sentiment: BRTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+1030.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.12 -
$1.19
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1030.4% below Wall St target ($13.00)
Fair Price Analysis
30-Day Fair Range
$1.12 -
$1.19
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.06
Resistance Level
$1.19
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.85
Wall Street Target
$13.00
(+1030.4%)
Revenue Growth (YoY)
-94.9%
Last updated: February 02, 2026 10:03 PM ET
Data refreshes hourly during market hours. Next update: 11:03 PM
Data refreshes hourly during market hours. Next update: 11:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 61 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 60 HOLD |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$13 | 58 HOLD |
